Literature DB >> 21471963

Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.

O Zolk1, M F Fromm.   

Abstract

Transporter proteins mediate the cellular uptake and efflux of a broad variety of endogenous compounds, drugs, and their metabolites. Their systemic plasma concentrations are determined, in particular, by drug transporters expressed in the small intestine, liver, and kidney. In addition, drug transporters expressed in peripheral tissues (e.g., skeletal muscle) are likely to influence organ-specific drug concentrations and side effects. This review summarizes current findings regarding the association between adverse drug reactions in humans and modification of the functions of certain transporters caused by genetic factors or simultaneously administered inhibitors. We focus on adverse drug reactions occurring in humans due to transport in the small intestine, liver, kidneys, and blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471963     DOI: 10.1038/clpt.2010.354

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  25 in total

1.  Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions.

Authors:  Navjotsingh Pabla; Alice A Gibson; Mike Buege; Su Sien Ong; Lie Li; Shuiying Hu; Guoqing Du; Jason A Sprowl; Aksana Vasilyeva; Laura J Janke; Eberhard Schlatter; Taosheng Chen; Giuliano Ciarimboli; Alex Sparreboom
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line.

Authors:  C Fahrmayr; J König; D Auge; M Mieth; K Münch; J Segrestaa; T Pfeifer; A Treiber; Mf Fromm
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 3.  Bioavailability of phytochemicals and its enhancement by drug delivery systems.

Authors:  Farrukh Aqil; Radha Munagala; Jeyaprakash Jeyabalan; Manicka V Vadhanam
Journal:  Cancer Lett       Date:  2013-02-19       Impact factor: 8.679

4.  Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

Authors:  Annemieke J M Nieuweboer; Shuiying Hu; Chunshan Gui; Bruno Hagenbuch; Inge M Ghobadi Moghaddam-Helmantel; Alice A Gibson; Peter de Bruijn; Ron H J Mathijssen; Alex Sparreboom
Journal:  Cancer Res       Date:  2014-04-22       Impact factor: 12.701

5.  Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.

Authors:  Sarinj Fattah; Abhijit Babaji Shinde; Maja Matic; Myriam Baes; Ron H N van Schaik; Karel Allegaert; Celine Parmentier; Lysiane Richert; Patrick Augustijns; Pieter Annaert
Journal:  Pharm Res       Date:  2017-03-31       Impact factor: 4.200

6.  Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells.

Authors:  C Fahrmayr; J König; D Auge; M Mieth; M F Fromm
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Clinically significant psychotropic drug-drug interactions in the primary care setting.

Authors:  Brett A English; Marcus Dortch; Larry Ereshefsky; Stanford Jhee
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

8.  Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides.

Authors:  Michael H Serrano-Wu; Gary M Coppola; Yongjin Gong; Alan D Neubert; Ricardo Chatelain; Kevin B Clairmont; Renee Commerford; Theresa Cosker; Thomas Daniels; Ying Hou; Monish Jain; Marlene Juedes; Lisha Li; Tara Mullarkey; Erik Rocheford; Moo Je Sung; Andrew Tyler; Qing Yang; Taeyoung Yoon; Brian K Hubbard
Journal:  ACS Med Chem Lett       Date:  2012-04-04       Impact factor: 4.345

Review 9.  Interaction of innovative small molecule drugs used for cancer therapy with drug transporters.

Authors:  K Mandery; H Glaeser; M F Fromm
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 10.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.